Total Payments
$3,552
2024 Payments
$709.85
Companies
18
Transactions
153
Medicare Patients
645
Medicare Billing
$44,848
Payment Breakdown by Category
Food & Beverage$3,486 (98.1%)
Education$66.36 (1.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,486 | 152 | 98.1% |
| Education | $66.36 | 1 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $807.85 | 30 | $0 (2024) |
| GENZYME CORPORATION | $650.82 | 30 | $0 (2024) |
| Galderma Laboratories, L.P. | $364.93 | 5 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $259.79 | 22 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $212.60 | 7 | $0 (2024) |
| VYNE Pharmaceuticals Inc. | $204.01 | 9 | $0 (2021) |
| Incyte Corporation | $171.23 | 9 | $0 (2023) |
| Janssen Biotech, Inc. | $165.24 | 14 | $0 (2022) |
| Lilly USA, LLC | $147.16 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $145.96 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $709.85 | 25 | ABBVIE INC. ($196.76) |
| 2023 | $739.11 | 44 | GENZYME CORPORATION ($210.62) |
| 2022 | $1,117 | 56 | ABBVIE INC. ($299.49) |
| 2021 | $986.47 | 28 | Galderma Laboratories, L.P. ($332.65) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Immunology | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.02 | General |
| Category: Immunology | ||||||
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: Immunology | ||||||
| 11/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: Immunology | ||||||
| 10/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Stemline Therapeutics Inc. | ELZONRIS (Drug) | Food and Beverage | In-kind items and services | $42.67 | General |
| Category: Oncology | ||||||
| 09/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: ONCOLOGY | ||||||
| 08/19/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Dermatology | ||||||
| 08/03/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, ZEPBOUND | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Immunology | ||||||
| 07/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Immunology | ||||||
| 07/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Immunology | ||||||
| 06/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $38.81 | General |
| Category: Immunology | ||||||
| 06/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Inflammation | ||||||
| 06/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $71.79 | General |
| Category: IMMUNOLOGY | ||||||
| 06/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: IMMUNOLOGY | ||||||
| 05/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: IMMUNOLOGY | ||||||
| 04/29/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.56 | General |
| Category: Immunology | ||||||
| 04/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.09 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $124.40 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 444 | 758 | $74,135 | $32,194 |
| 2022 | 7 | 151 | 222 | $20,775 | $8,917 |
| 2021 | 1 | 12 | 17 | $2,550 | $1,277 |
| 2020 | 2 | 38 | 44 | $8,400 | $2,460 |
Total Patients
645
Total Services
1,041
Medicare Billing
$44,848
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 81 | 125 | $13,250 | $7,503 | 56.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 67 | $10,251 | $5,675 | 55.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 68 | 106 | $11,766 | $4,412 | 37.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 34 | 40 | $6,000 | $2,997 | 49.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 31 | 33 | $7,920 | $2,911 | 36.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 37 | 43 | $9,632 | $2,828 | 29.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 31 | 34 | $2,822 | $1,428 | 50.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 49 | 246 | $3,690 | $1,285 | 34.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 20 | 30 | $3,600 | $1,181 | 32.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $2,720 | $1,142 | 42.0% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 13 | 18 | $2,484 | $833.04 | 33.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 30 | $4,590 | $2,339 | 51.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 31 | 37 | $4,107 | $1,568 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 28 | $2,968 | $1,535 | 51.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 16 | 20 | $3,000 | $1,436 | 47.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 15 | 17 | $3,808 | $1,110 | 29.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 14 | $1,162 | $542.21 | 46.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 24 | 76 | $1,140 | $387.48 | 34.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 17 | $2,550 | $1,277 | 50.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 20 | 26 | $3,900 | $1,400 | 35.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 18 | 18 | $4,500 | $1,060 | 23.6% |
About Ashley Wu
Ashley Wu is a Registered Nurse healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/16/2017. The National Provider Identifier (NPI) number assigned to this provider is 1447799911.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley Wu has received a total of $3,552 in payments from pharmaceutical and medical device companies, with $709.85 received in 2024. These payments were reported across 153 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,486).
As a Medicare-enrolled provider, Wu has provided services to 645 Medicare beneficiaries, totaling 1,041 services with total Medicare billing of $44,848. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Brooklyn, NY
- Active Since 02/16/2017
- Last Updated 10/18/2019
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1447799911
Products in Payments
- DUPIXENT (Biological) $838.14
- SKYRIZI (Biological) $601.86
- AKLIEF (Drug) $172.78
- OPZELURA (Drug) $171.23
- ORACEA (Drug) $159.87
- COSENTYX (Drug) $152.92
- AMZEEQ (Drug) $151.01
- Sotyktu (Drug) $145.96
- RINVOQ (Biological) $128.70
- TALTZ (Drug) $120.21
- Cimzia (Drug) $106.32
- REMICADE (Biological) $103.19
- EUCRISA (Drug) $81.67
- HUMIRA (Biological) $77.29
- COSENTYX (Biological) $63.86
- TREMFYA (Drug) $62.05
- ZILXI (Drug) $53.00
- Ilumya (Biological) $46.83
- ELZONRIS (Drug) $42.67
- VARITHENA (Device) $40.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Brooklyn
Dr. Kathleen Brooks, Nurse Practitioner, NURSE PRACTITIONER
Registered Nurse — Payments: $5,503
Registered Nurse $5,503
Alina Boshakova, Rn, RN
Registered Nurse — Payments: $3,716
Registered Nurse $3,716
Raisa Harrington, Pmhnp-Bc, PMHNP-BC
Registered Nurse — Payments: $3,665
Registered Nurse $3,665
Jacob Levy, Ms, Fnp, MS, FNP
Registered Nurse — Payments: $3,565
Registered Nurse $3,565
Victoria Liu, Np, NP
Registered Nurse — Payments: $3,090
Registered Nurse $3,090
Bernadette Dolce, Fnp, FNP
Registered Nurse — Payments: $3,048
Registered Nurse $3,048